PHASE 2 TRIAL OF PRM-151, AN ANTI-FIBROTIC AGENT, IN PATIENTS WITH MYELOFIBROSIS: STAGE 1 RESULTSSrdan Verstovsek,Ruben A. Mesa,Lynda M. Foltz,Vikas Gupta,John Mascarenhas,Ellen K. Ritchie,Ronald Hoffman,Richard T. Silver,Wan-Jen Hong,Marina Kremyanskaya,Elizabeth G. Trehu,Hagop M. Kantarjian,Jason R. GotlibBLOOD(2014)引用 51|浏览17暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要